Policy briefing on improving the full-cycle and all-channel drug pricing mechanism

China SCIO | April 15, 2026

Li Jiangning, director general of the Department of Drug Regulation of the National Medical Products Administration, attends a policy briefing in Beijing, April 15, 2026. [Photo by Xu Xiang/China SCIO]

< 1 2 3 4 5 6 7 8 >